Stock Events

Stock Events

10x Genomics 

$62.65
189
-$0.57-0.9% Friday 20:00
-$0.26-0.42%Friday 23:30After hours

Statistics

Day High
62.76
Day Low
62.56
52W High
66.94
52W Low
11.16
Volume
67,113
Avg. Volume
-
Mkt Cap
8.16B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.47
-0.22
0.03
0.28
Expected EPS
-0.266444
Actual EPS
N/A

Financials

-6.77%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
642.82MRevenue
-43.54MNet Income

Analyst Ratings

46.20Average Price Target
The highest estimate is 70.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
36%
Hold
64%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TXG. It's not an investment recommendation.
Apple
47
AAPL
NVIDIA
47
NVDA
Microsoft
44
MSFT
Tesla
42
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap32.55B
Illumina provides sequencing and array-based solutions for genetic analysis, directly competing in the genomics space with technologies that overlap with 10x Genomics' offerings.
Pacific Biosciences of California
PACB
Mkt Cap435.16M
Pacific Biosciences offers long-read sequencing technologies that compete with 10x Genomics' products for genomic and transcriptomic analysis.
Bionano Genomics
BNGO
Mkt Cap13.78M
Bionano Genomics provides optical genome mapping solutions, which compete with 10x Genomics' chromosomal conformation capture technologies.
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Intellia Therapeutics is involved in CRISPR gene editing, a field that requires detailed genomic analysis, where 10x Genomics' products are used.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is another key player in the gene editing space, relying on genomic insights where 10x Genomics' technologies can be applied.
Editas Medicine
EDIT
Mkt Cap485.31M
Editas Medicine operates in the genome editing sector, competing for the same genomic analysis market as 10x Genomics.
Teladoc Health
TDOC
Mkt Cap1.18B
Teladoc Health, while primarily a telehealth company, is expanding into primary care and chronic condition monitoring, indirectly competing with 10x Genomics in the data analysis and personalized medicine space.
Guardant Health
GH
Mkt Cap21.67B
Guardant Health specializes in liquid biopsies and cancer diagnostics, competing with 10x Genomics in the genomic analysis market for oncology.
Twist Bioscience
TWST
Mkt Cap8.87B
Twist Bioscience operates in the synthetic biology space, producing synthetic DNA that is used in many of the same applications as 10x Genomics' products.

About

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
Show more...
CEO
Serge Saxonov
Employees
1178
Country
United States
ISIN
US88025U1097
WKN
000A2PPQJ

Listings

LSE
GB
0A88.LSE
STU
DE
1KJ.STU
XNAS
US
TXG
MU
DE
1KJ.MU

0 Comments

Share your thoughts

FAQ

What is 10x Genomics stock price today?▼
The current price of TXG is $62.65 USD — it has decreased by -0.9% in the past 24 hours. Watch 10x Genomics stock price performance more closely on the chart.
What is 10x Genomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange 10x Genomics stocks are traded under the ticker TXG.
Is 10x Genomics stock price growing?▼
TXG stock has risen by +1.8% compared to the previous week, the month change is a +32.01% rise, over the last year 10x Genomics has showed a +348.78% increase.
What is 10x Genomics market cap?▼
Today 10x Genomics has the market capitalization of 8.16B
When is the next 10x Genomics earnings date?▼
10x Genomics is going to release the next earnings report on November 04, 2026.
What were 10x Genomics earnings last quarter?▼
TXG earnings for the last quarter are -0.14 USD per share, whereas the estimation was -0.24 USD resulting in a +42.41% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is 10x Genomics revenue for the last year?▼
10x Genomics revenue for the last year amounts to 642.82M USD.
What is 10x Genomics net income for the last year?▼
TXG net income for the last year is -43.54M USD.
How many employees does 10x Genomics have?▼
As of September 05, 2026, the company has 1,178 employees.
In which sector is 10x Genomics located?▼
10x Genomics operates in the Health & Wellness sector.
When did 10x Genomics complete a stock split?▼
10x Genomics has not had any recent stock splits.
Where is 10x Genomics headquartered?▼
10x Genomics is headquartered in PLEASANTON, United States.